Malignant neoplasm of left fallopian tube
ICD-10 C57.02 is a billable code used to indicate a diagnosis of malignant neoplasm of left fallopian tube.
Malignant neoplasm of the left fallopian tube is a rare gynecologic malignancy characterized by the uncontrolled growth of abnormal cells in the left fallopian tube. This condition often presents with non-specific symptoms such as abdominal pain, abnormal vaginal bleeding, or pelvic mass. Diagnosis typically involves imaging studies, such as ultrasound or CT scans, and histopathological examination following biopsy or surgical resection. The staging of fallopian tube cancer is crucial for determining treatment options and prognosis, with stages ranging from localized disease (Stage I) to advanced disease (Stage IV) involving distant metastasis. CA-125, a tumor marker, is often elevated in patients with fallopian tube cancer and can be used to monitor treatment response and disease recurrence. Surgical intervention, including salpingo-oophorectomy or total abdominal hysterectomy with staging, is the primary treatment modality, often followed by chemotherapy depending on the stage and histological type of the tumor.
Detailed surgical reports, pathology results, and staging information.
Diagnosis and treatment planning for patients with suspected fallopian tube malignancy.
Ensure accurate staging and documentation of tumor markers like CA-125.
Comprehensive imaging reports detailing findings related to the fallopian tube.
Imaging for suspected gynecologic malignancies.
Clear documentation of imaging techniques and findings to support diagnosis.
Used for surgical treatment of left fallopian tube malignancy.
Operative report detailing the procedure and findings.
Ensure accurate coding based on the surgical approach and findings.
CA-125 is a tumor marker that is often elevated in patients with fallopian tube cancer. It is used to aid in diagnosis, monitor treatment response, and check for recurrence.
